Stem Cell Research Funding Blockade is Featured Topic at Upcoming World Stem Cell Summit in Detroit, Oct.4-6

Sherley v. Sebelius, Congressional action and NIH Guidelines to be scrutinized at global meeting

WASHINGTON--(BUSINESS WIRE)-- The injunction in the case of Sherely v. Sebelius halting federal funding of embryonic stem cell research will be the subject of intense focus at the 2010 World Stem Cell Summit at the Detroit Marriott Renaissance Center, October 4-6, according to Bernard Siegel, co-chair of the Summit and executive director of the Genetics Policy Institute (GPI), the producer of the event.

According to Siegel, “The injunction casts a pall over the field, threatening to stop promising research in its tracks, squandering the government’s substantial investment and crushing the hope of patients worldwide. The annual Summit gathers the top researchers, industry experts, policy-makers, regulators, nonprofit leaders and patients from around the world and serves as the ideal forum to understand the scope of the problem and determine the effective strategies to foster lifesaving research.”

Most notably, the summit program now includes the plenary session, “Stem Cell Awareness Day Town Hall Meeting- Sherley v. Sebelius and Beyond”, an open forum for attendees to address their concerns.

Additional presentations related to the Sherley case and related matters include:

“The NIH Guidelines and Sherley v. Sebelius - Implications for the Future of Stem Cell Research,” featuring Dr. Story Landis, head of the Stem Cell Task Force of the National Institutes of Health.

Keynote Address: Senator Carl Levin (Michigan)

Empowering the Stem Cell Advocacy Movement with patient-advocates Danny Heumann, Sabrina Cohen and Grant Albrecht, moderated by Bernard Siegel (GPI).

“The Morality of Embryo Use” an expert luncheon topic hosted by Harvard moral philosopher, Louis M. Guenin, author of the prize-winning book by the same title.

“Embryonic Stem Cell Research Oversight Committee Workshop”designed for institutional committee members.

The 2010 World Stem Cell Summit is the flagship international event uniting the stem cell community by bringing together the stem cell community to network and learn from each other.

The co-hosts for the 2010 Summit include the State of Michigan, the Michigan Economic Development Corporation, University of Michigan, Michigan State University, Wayne State University and the University Research Corridor.

In 2010, the Summit will attract more than 1,000 attendees from 30 nations, 60 exhibitors and more than 200 endorsing organizations and media partners. Science & Education partners include Oakland University and The Taubman Foundation. Some of the sponsors and endorsers include the American Red Cross, Harvard Stem Cell Institute, Foundation Fighting Blindness, and among public companies, Beckman Coulter, Millipore, NeoStem and Roche.

The largest and most comprehensive multi-track stem cell conference, the Summit features more than 150 international speakers and 50 hours of in-depth science, business and society presentations. No other stem cell conference offers the breadth of content and global perspective. The agenda works to unite, educate, and harmonize the global stem cell community. For more information and to register, visit www.worldstemcellsummit.com.

The Summit kick-off takes place on Sunday, Oct. 3 with the “Stem Cell Public Education Day” at the Detroit Science Center. The event is free to the public and will offer presentations by experts on “Stem Cell 101,” “Patient Guidelines to Safe Stem Cell Therapies,” hands-on science displays, documentaries and more.



CONTACT:

The Genetics Policy Institute
Bernard Siegel, 305-801-4928
[email protected]

KEYWORDS:   United States  North America  District of Columbia  Michigan

INDUSTRY KEYWORDS:   Seniors  Stem Cells  Religion  Education  Primary/Secondary  University  Technology  Networks  Software  Semiconductor  Practice Management  Health  AIDS  Biotechnology  Cardiology  Clinical Trials  Dental  Genetics  Hospitals  Infectious Diseases  Public Policy/Government  Medical Devices  Congressional News/Views  Mental Health  Elections/Campaigns  Courts  Oncology  Optical  Pharmaceutical  Radiology  Other Policy Issues  Social Media  Philanthropy  Professional Services  Children  Parenting  Legal  Defense  Communications  Contracts  Other Defense  Public Relations/Investor Relations  Other Science  Publishing  Other Philanthropy  Other Communications  Diabetes  FDA  Consumer  Medical Supplies  Family  Science  Gay & Lesbian  Foundation  Fund Raising  General Health  Managed Care  Physical Therapy

MEDIA:

Logo
 Logo